Parallax Volatility Advisers’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.1M Buy
62,500
+12,500
+25% +$2.91M 0.04% 319
2025
Q4
$10.3M Sell
50,000
-8,600
-15% -$1.7M 0.02% 446
2025
Q3
$10.9M Sell
58,600
-418,000
-88% -$71.6M 0.02% 438
2025
Q2
$72.8M Buy
476,600
+31,300
+7% +$4.81M 0.16% 94
2025
Q1
$73.8M Buy
445,300
+28,500
+7% +$4.46M 0.2% 94
2024
Q4
$60.3M Buy
416,800
+46,500
+13% +$7.21M 0.12% 136
2024
Q3
$60M Sell
370,300
-127,500
-26% -$20.3M 0.11% 144
2024
Q2
$72.8M Sell
497,800
-196,500
-28% -$29.2M 0.16% 105
2024
Q1
$110M Buy
694,300
+122,900
+22% +$19.6M 0.25% 77
2023
Q4
$89.6M Sell
571,400
-48,400
-8% -$7.42M 0.18% 95
2023
Q3
$96.5M Sell
619,800
-246,300
-28% -$40.6M 0.22% 78
2023
Q2
$143M Buy
866,100
+427,300
+97% +$69M 0.31% 53
2023
Q1
$68M Sell
438,800
-2,177,800
-83% -$352M 0.14% 136
2022
Q4
$462M Buy
2,616,600
+1,740,800
+199% +$301M 0.72% 15
2022
Q3
$143M Sell
875,800
-333,700
-28% -$56.5M 0.22% 70
2022
Q2
$215M Buy
1,209,500
+353,200
+41% +$62.9M 0.2% 79
2022
Q1
$152M Buy
856,300
+239,700
+39% +$40.8M 0.08% 78
2021
Q4
$105M Buy
616,600
+35,000
+6% +$5.73M 0.12% 109
2021
Q3
$93.9M Sell
581,600
-1,480,000
-72% -$252M 0.09% 158
2021
Q2
$340M Buy
+2,061,600
New +$341M 0.47% 23
2021
Q1
Sell
-1,123,100
Closed -$177M 1690
2020
Q4
$177M Sell
1,123,100
-228,600
-17% -$33.7M 0.18% 89
2020
Q3
$201M Sell
1,351,700
-174,300
-11% -$25.8M 0.15% 114
2020
Q2
$215M Sell
1,526,000
-195,600
-11% -$28.5M 0.25% 54
2020
Q1
$226M Buy
1,721,600
+306,600
+22% +$43.5M 0.29% 48
2019
Q4
$206M Buy
1,415,000
+262,800
+23% +$35.6M 0.24% 64
2019
Q3
$149M Buy
1,152,200
+724,900
+170% +$95.5M 0.17% 75
2019
Q2
$59.5M Buy
427,300
+335,700
+366% +$46.5M 0.06% 157
2019
Q1
$12.8M Sell
91,600
-670,300
-88% -$89.8M 0.01% 413
2018
Q4
$98.3M Buy
761,900
+710,300
+1,377% +$99.1M 0.13% 125
2018
Q3
$7.13M Sell
51,600
-136,500
-73% -$18.1M 0.01% 583
2018
Q2
$22.8M Buy
188,100
+118,000
+168% +$14.7M 0.03% 244
2018
Q1
$8.98M Buy
+70,100
New +$9.47M 0.01% 410
2017
Q3
Sell
-17,800
Closed -$2.35M 2734
2017
Q2
$2.35M Sell
17,800
-7,200
-29% -$918K ﹤0.01% 788
2017
Q1
$3.11M Sell
25,000
-130,800
-84% -$15.6M 0.01% 717
2016
Q4
$17.9M Buy
155,800
+122,000
+361% +$14.1M 0.04% 298
2016
Q3
$3.99M Sell
33,800
-413,800
-92% -$50.2M 0.01% 765
2016
Q2
$54.3M Sell
447,600
-1,238,900
-73% -$141M 0.11% 119
2016
Q1
$182M Buy
1,686,500
+1,611,000
+2,134% +$167M 0.4% 35
2015
Q4
$7.76M Sell
75,500
-578,200
-88% -$58.1M 0.02% 526
2015
Q3
$61M Buy
653,700
+652,800
+72,533% +$63.1M 0.14% 111
2015
Q2
$88K Sell
900
-79,100
-99% -$7.92M ﹤0.01% 2325
2015
Q1
$8.05M Sell
80,000
-102,000
-56% -$10.4M 0.02% 544
2014
Q4
$19M Buy
+182,000
New +$19.2M 0.06% 305
2014
Q3
Sell
-36,600
Closed -$3.83M 4320
2014
Q2
$3.83M Sell
36,600
-235,400
-87% -$23.8M 0.02% 556
2014
Q1
$26.7M Buy
+272,000
New +$25.2M 0.16% 125
2013
Q4
Sell
-355,000
Closed -$30.8M 3465
2013
Q3
$30.8M Sell
355,000
-257,700
-42% -$23.1M 0.16% 118
2013
Q2
$52.6M Buy
+612,700
New +$52M 0.25% 73

Other funds holding JNJ

Parallax Volatility Advisers's JNJ Position: Q1 2026 in Review

Parallax Volatility Advisers reduced its Johnson & Johnson (JNJ) stake by 73% in Q1 2026, selling an estimated $8.47M and leaving 13,609 shares worth $3.08M. The position accounts for 0.01% of the portfolio, ranked #699.

Parallax Volatility Advisers first reported a position in JNJ in Q4 2013 and has held it in 23 quarters since. The position peaked at $92M in Q3 2020. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Parallax Volatility Advisers held 13,609 shares of Johnson & Johnson worth $3.08M as of Q1 2026.
  • Parallax Volatility Advisers sold 36,349 Johnson & Johnson shares in Q1 2026, an estimated $8.47M.
  • Johnson & Johnson made up 0.01% of Parallax Volatility Advisers's portfolio in Q1 2026, its #699 holding.
  • Parallax Volatility Advisers first reported a position in Johnson & Johnson in Q4 2013 and has held it in 23 quarters since.
  • Parallax Volatility Advisers's Johnson & Johnson position peaked at $92M in Q3 2020.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.